Additionally, the percentage of TOX+ IL-4+ positive cells was significantly higher in CTCL than in AD (Figure 1F), and the expression of TOX was not restricted to CD4+ T cells in AD (Figures 1G, H), which is contrary to that in CTCL. This evidence concerns the gene TSPYL2 and primary cutaneous T-cell non-Hodgkin lymphoma.